Neuroimmune-competent human brain organoid model of diffuse midline glioma
Neuro-Oncology · 10.02.2025 · 27 (2) · 369-382
DOI: 10.1093/neuonc/noae245 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuro-Oncology, online erschienen am 19.11.2024. Verfasst von Katharina Sarnow und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Boston Children's Hospital, Boston, MA, USA. Hauptthemen laut MEDLINE: Organoids, Brain Neoplasms, Glioma, Microglia. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS.
Abstract (Originalsprache)
Background
Pediatric high-grade gliomas, such as diffuse midline glioma (DMG), have a poor prognosis and lack curative treatments. Current research models of DMG primarily rely on human DMG cell lines cultured in vitro or xenografted into the brains of immunodeficient mice. However, these models are insufficient to recapitulate the complex cell-cell interactions between DMG and the tumor-immune microenvironment (TIME), therefore fall short of accurately reflecting how efficacious therapeutic agents or combinations will be in the clinical setting.
Methods
To address these challenges, we developed a neuroimmune-competent brain/tumor fusion organoid model system consisting entirely of human cells to investigate the interactions between DMG cells and the primary innate immune cells of the brain, microglia, in the TIME at both cellular and subcellular levels. We generated microglia-containing brain organoids (MiCBOs) that carry morphologically mature, motile microglia and multiple subtypes of neurons to mimic the brain tumor microenvironment. These organoids were then fused with H3K27M mutant, TP53P27R/K132R DMG tumor spheroids to create the MiCBO-tumor fusion (MiCBO-TF) model.
Results
We utilized live imaging methods to simultaneously track the mobility of microglial cell bodies and the motility of their process, as well as the behavior of tumor cells within a human brain tissue environment. Our MiCBO-TF model faithfully recapitulated the diffuse infiltration pattern of DMG into brain tissue and revealed that microglial mobility and interactions with tumor cells are highly influenced by external factors and the surrounding tissue environment.
Conclusions
The MiCBO-TF model represents a powerful platform for both mechanistic investigations and the development of precision medicine approaches for DMG.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Boston Children's Hospital, Boston, MA, USA.
- Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.
- Harvard College, Cambridge, MA, USA.
- Whitehead Institute for Biomedical Research, Cambridge, MA, USA.
- Department of Neurosurgery, Harvard Medical School, Boston, MA, USA.
ORCID-Profile: Katharina Sarnow
Förderung
- NICHD NIH HHS
Zitieren
APA
Sarnow, K., Majercak, E., Qurbonov, Q., Cruzeiro, G. A. V., Jeong, D., Haque, I. A., Khalil, A., Baird, L. C., Filbin, M. G., & Tang, X. (2025). Neuroimmune-competent human brain organoid model of diffuse midline glioma. Neuro-Oncology, 27(2), 369-382. https://doi.org/10.1093/neuonc/noae245
Vancouver
Sarnow K, Majercak E, Qurbonov Q, Cruzeiro GAV, Jeong D, Haque IA, et al. Neuroimmune-competent human brain organoid model of diffuse midline glioma. Neuro-Oncology. 2025;27(2):369-382. doi:10.1093/neuonc/noae245
BibTeX
@article{Sarnow2025,
author = {Sarnow, Katharina and Majercak, Emma and Qurbonov, Qurbonali and Cruzeiro, Gustavo A V and Jeong, Daeun and Haque, Ishraq A and Khalil, Andrew and Baird, Lissa C and Filbin, Mariella G and Tang, Xin},
title = {Neuroimmune-competent human brain organoid model of diffuse midline glioma},
journal = {Neuro-Oncology},
year = {2025},
volume = {27},
number = {2},
pages = {369--382},
doi = {10.1093/neuonc/noae245}
}
EUVIMED